Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00004496 · ClinicalTrials.gov registry record · Phase 1

Phase I Study of Alpha-Melanocyte Stimulating Hormone in Patients With Acute Renal Failure

A Phase 1 study of Acute Renal Failure, sponsored by University of Texas.

Completed
Registry status
Phase 1
Development phase
45
Enrollment target
2
Study locations

NCT00004496 is a Phase 1 study of Acute Renal Failure that has completed, run by University of Texas. The registered enrollment target is 45 participants, below the 259-participant average among 5 other Acute Renal Failure trials with a reported enrollment target (83% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00004496, a Phase 1 study of Acute Renal Failure, has completed, sponsored by University of Texas.

COMPLETED
Registry status
Phase 1
Development phase
45 participants
Enrollment target
2
Study locations

Study Summary

OBJECTIVES: I. Determine the maximum tolerated dose and safety of alpha-melanocyte stimulating hormone (alpha-MSH) in patients with acute renal failure. II. Determine the safety and pharmacokinetics of alpha-MSH in patients at high risk of acute renal failure after renal transplantation. III. Determine the safety and pharmacokinetics of alpha-MSH in patients with established ischemic acute renal failure. IV. Determine the effect of alpha-MSH on interleukin-10 pharmacokinetics.

Conditions Studied

Acute Renal Failure

Interventions

  • DRUG alpha-melanocyte stimulating hormone

Study Locations (2)

Texas

  • University of Texas Southwestern Medical Center at Dallas - Dallas
  • Baylor University Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 1999-02
Est. Completion 2003-09
Phase Phase 1

Sponsor

University of Texas

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00004496

The ClinicalTrials.gov registry entry for NCT00004496 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 259-participant average among 5 other Acute Renal Failure trials with a reported enrollment target (83% lower). The listed sponsor is University of Texas, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Acute Renal Failure appearing as the primary indexed condition, and to 1 intervention - of which alpha-melanocyte stimulating hormone is the first listed.

NCT00004496 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT00004496 about?

NCT00004496 is a clinical study titled "Phase I Study of Alpha-Melanocyte Stimulating Hormone in Patients With Acute Renal Failure". OBJECTIVES: I. Determine the maximum tolerated dose and safety of alpha-melanocyte stimulating hormone (alpha-MSH) in patients with acute renal failure. II. Determine the safety and pharmacokinetics of alpha-MSH in patients at high risk of acute renal failure after renal transplantation. III. Dete...

What is the current status of trial NCT00004496?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 45 participants. The study started on 1999-02. Estimated completion is 2003-09.

What conditions does trial NCT00004496 study?

This clinical trial studies the following conditions: Acute Renal Failure.

What interventions are being tested in trial NCT00004496?

The interventions under investigation include: alpha-melanocyte stimulating hormone (DRUG).

Who is sponsoring clinical trial NCT00004496?

This trial is sponsored by University of Texas, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00004496 being conducted?

This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Acute Renal Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Acute Renal Failure

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.